The Wall Street Journal’s coverage of Within3’s $100 million financings round.
Read More
Crain’s Cleveland covers Within3’s financing round, which will be used to accelerate product development, fuel international expansion, and build infrastructure to outpace increasing demand.
Within3 closed over $100 million in growth funding in a financing round led by Insight Partners, with participation from Silversmith Capital Partners to accelerate product innovation, build infrastructure to outpace growing demand, and fuel international expansion.
Within3 announces a new certification program to help healthcare and life science communications agencies support their clients’ shift to a virtual environment for complex engagements like clinical trial design and medical advisory boards.
Remote work and collaboration will be the new normal for life sciences companies, according to Within3 CEO Lance Hill in PharmaTimes.
Lance Hill, CEO at Within3, and Richard Warren outline how life sciences companies can be successful with remote clinical trials and other virtual engagements.
